Silong Zhang

16PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsManufacturing roboticsTissue engineeringPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 23, 2026
A Selective ERα Photodegrader for Precise and Efficient Breast Cancer Treatment.

|Sep 22, 2026
Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.

|Jun 19, 2026
ROS-Mediated Controllable Targeted Protein Degradation: Progress and Reflections.

|Feb 12, 2026
Dual inhibition of ERα/NF-κB pathways coupled with sonodynamic therapy via a multifunctional AIEgen.

Longli Hu, Yu Zhang, Ziwei Wang

|Jul 15, 2025
Design of pyrrolo[2,3-d]pyrimidine-endoperoxide hybrids as first-in-class dual degraders of cyclin D1/3 and CDK4/6 with potent antiproliferative effects.

Zhen Cui, Yuanli Yang, Changqi Wang

|Jun 05, 2025
A pyrene-based HDAC inhibitor for dual-action therapy of breast cancer.

Qizhang Li, Xing Lu, Yuanli Yang

Pageof 3

Frequent Collaborators

9 joint publications

Huan He

5 joint publications

Yi Liu

2 joint publications

Jian Min

2 joint publications

Hang Zhong